CVS Drug Plans to Allow No-Cost Access to OTC Birth Control [BNN Bloomberg (Canada)]
Perrigo Company plc Ordinary Shares (PRGO)
Last perrigo company plc ordinary shares earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
perrigo.investorroom.com
Company Research
Source: BNN Bloomberg
Opill, the nonprescription drug from Perrigo Co., will be added to the preventive services oral contraceptives list and will be covered at no cost for many plan sponsors, CVS Caremark said in a pharmacy update dated March 28 that was viewed by Bloomberg News. Perrigo is “thrilled” that the CVS plans will expand access to Opill, Triona Schmelter, Perrigo's executive vice president for consumer self-care Americas, said in a statement. The drugmaker's shares rose as much as 4.6% on the news before paring gains. A CVS representative referred to the pharmacy update. CVS Caremark was the largest prescription drug manager in 2022, with one-third of the market, according to Drug Channels Institute. The company says it serves 89 million people, so the move has the potential to expand access to free, nonprescription birth control to vast numbers of Americans. The US Food and Drug Administration cleared Opill for nonprescription use last summer, making it the country's first over-the-coun
Show less
Read more
Impact Snapshot
Event Time:
PRGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRGO alerts
High impacting Perrigo Company plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRGO
News
- Perrigo gets offer to sell its HRA Pharma rare diseases unit [Seeking Alpha]Seeking Alpha
- Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million [Yahoo! Finance]Yahoo! Finance
- Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 MillionPR Newswire
- Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 [Yahoo! Finance]Yahoo! Finance
- Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024PR Newswire
PRGO
Earnings
- 2/27/24 - Beat
PRGO
Sec Filings
- 4/25/24 - Form 8-K
- 4/9/24 - Form 4
- 4/9/24 - Form 4
- PRGO's page on the SEC website